These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8772825)
1. Primary central nervous system lymphoma. Khubchandani SR; Chitale AR Indian J Cancer; 1995 Dec; 32(4):200-6. PubMed ID: 8772825 [TBL] [Abstract][Full Text] [Related]
2. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155 [TBL] [Abstract][Full Text] [Related]
3. Primary malignant large bowel lymphoma. Pandey M; Kothari KC; Wadhwa MK; Patel HP; Patel SM; Patel DD Am Surg; 2002 Feb; 68(2):121-6. PubMed ID: 11842954 [TBL] [Abstract][Full Text] [Related]
4. Treatment results of tonsillar lymphoma: a 10-year experience. Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316 [TBL] [Abstract][Full Text] [Related]
5. Primary colorectal lymphomas. Wong MT; Eu KW Colorectal Dis; 2006 Sep; 8(7):586-91. PubMed ID: 16919111 [TBL] [Abstract][Full Text] [Related]
6. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors. Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169 [TBL] [Abstract][Full Text] [Related]
7. [Primary malignant non-Hodgkin's lymphomas of the central nervous system in immunocompetent patients: diagnostic, prognostic and therapeutic criteria]. Ferracini R Pathologica; 1997 Apr; 89(2):146-54. PubMed ID: 9411361 [TBL] [Abstract][Full Text] [Related]
8. [Intraocular non-Hodgkin's lymphoma and its therapy-- a case series of ten patients]. Siepmann K; Rohrbach JM; Duncker G; Zierhut M Klin Monbl Augenheilkd; 2004 Apr; 221(4):266-72. PubMed ID: 15118956 [TBL] [Abstract][Full Text] [Related]
9. Is central nervous system prophylaxis necessary in ocular adnexal lymphoma? Restrepo A; Raez LE; Byrne GE; Johnson T; Ossi P; Benedetto P; Hamilton K; Whitcomb CC; Cassileth PA Crit Rev Oncog; 1998; 9(3-4):269-73. PubMed ID: 10201631 [TBL] [Abstract][Full Text] [Related]
11. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate. Plotkin SR; Betensky RA; Hochberg FH; Grossman SA; Lesser GJ; Nabors LB; Chon B; Batchelor TT Clin Cancer Res; 2004 Sep; 10(17):5643-6. PubMed ID: 15355887 [TBL] [Abstract][Full Text] [Related]
12. Non-Hodgkin lymphoma of the breast. Ganjoo K; Advani R; Mariappan MR; McMillan A; Horning S Cancer; 2007 Jul; 110(1):25-30. PubMed ID: 17541937 [TBL] [Abstract][Full Text] [Related]
13. [Primary central nervous system malignant lymphoma originating from the cerebellum and extending along the lower cranial nerves]. Sasahara A; Kawamata T; Kubo O; Okami N; Kawamura H; Hori T No Shinkei Geka; 2000 Oct; 28(10):879-83. PubMed ID: 11070908 [TBL] [Abstract][Full Text] [Related]
14. Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome. Ustun C; Reid-Nicholson M; Nayak-Kapoor A; Jones-Crawford J; McDonald K; Jillella AP; Ramalingam P Ann Hematol; 2009 Apr; 88(4):351-8. PubMed ID: 18787825 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma. Tomita N; Kodama F; Kanamori H; Motomura S; Ishigatsubo Y Cancer; 2002 Aug; 95(3):576-80. PubMed ID: 12209750 [TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin lymphomas of the central nervous system. Clinico-pathologic and immunohistochemical study of 147 cases. Ferracini R; Pileri S; Bergmann M; Sabattini E; Rigobello L; Gambacorta M; Galli C; Manetto V; Frank G; Godano U Pathol Res Pract; 1993 Apr; 189(3):249-60. PubMed ID: 8332570 [TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system non-Hodgkin's lymphoma (PCNSL): does age and histology at presentation affect outcome? Schaller C; Kelly PJ Zentralbl Neurochir; 1996; 57(3):156-62. PubMed ID: 8794548 [TBL] [Abstract][Full Text] [Related]
18. A review of histology of bone marrow trephine in malignant lymphomas. Durosinmi MA; Mabayoje VO; Akinola NO Niger J Med; 2003; 12(4):198-201. PubMed ID: 14768193 [TBL] [Abstract][Full Text] [Related]
19. Low-grade primary central nervous system lymphoma in immunocompetent patients. Jahnke K; Thiel E; Schilling A; Herrlinger U; Weller M; Coupland SE; Krümpelmann U; Stein H; Korfel A Br J Haematol; 2005 Mar; 128(5):616-24. PubMed ID: 15725082 [TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. Poortmans PM; Kluin-Nelemans HC; Haaxma-Reiche H; Van't Veer M; Hansen M; Soubeyran P; Taphoorn M; Thomas J; Van den Bent M; Fickers M; Van Imhoff G; Rozewicz C; Teodorovic I; van Glabbeke M; J Clin Oncol; 2003 Dec; 21(24):4483-8. PubMed ID: 14597741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]